Literature DB >> 29175899

Prospective cohort study showing persistent HSV-2 shedding in women with genital herpes 2 years after acquisition.

Meena Ramchandani1, Stacy Selke2, Amalia Magaret2,3,4, Gail Barnum2, Meei-Li Wu Huang2, Lawrence Corey1,2,4, Anna Wald1,2,4,5.   

Abstract

OBJECTIVES: Herpes simplex virus type 2 (HSV-2) is a prevalent infection with great variability in clinical and virological manifestations among individuals. This prospective cohort study aims to evaluate the natural history of HSV-2 reactivation in the genital area in the same group of women over time.
METHODS: Eighteen immunocompetent HSV-2 seropositive women were evaluated for viral shedding for 70 consecutive days within a median of 8 months (range 1-24 months) of HSV-2 acquisition and again approximately 2.5 years later from the original study. Participants obtained daily swabs of genital secretions for HSV PCR and recorded genital symptoms.
RESULTS: The viral shedding rate was 29% during the initial study and 19% in the follow-up study (32% reduction, P=0.019). Subclinical shedding rate also decreased from 24% to 13% (37% reduction, P=0.032), as did the rate of days with genital lesions from 22% to 15% (33% reduction, P=0.24). The mean copy number during viral shedding remained unchanged over time at 4.8 log10 c/mL (SD=2.0 and 1.6 during each study, respectively, P=0.33). Women with high viral shedding rates in the past were likely to continue to have high shedding rates (r=0.63, P=0.005).
CONCLUSIONS: Despite some reduction, high viral shedding rates persist in women with genital HSV-2 greater than 2 years after acquisition. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  genital herpes; herpes simplex virus type 2; natural history; viral shedding

Mesh:

Substances:

Year:  2017        PMID: 29175899      PMCID: PMC6463512          DOI: 10.1136/sextrans-2017-053244

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  10 in total

1.  Herpes simplex virus-2 transmission probability estimates based on quantity of viral shedding.

Authors:  Joshua T Schiffer; Bryan T Mayer; Youyi Fong; David A Swan; Anna Wald
Journal:  J R Soc Interface       Date:  2014-03-26       Impact factor: 4.118

2.  Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment.

Authors:  A Wald; L Corey; R Cone; A Hobson; G Davis; J Zeh
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

3.  Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study.

Authors:  R H Lyles; A Muñoz; T E Yamashita; H Bazmi; R Detels; C R Rinaldo; J B Margolick; J P Phair; J W Mellors
Journal:  J Infect Dis       Date:  2000-03       Impact factor: 5.226

4.  Virologic and immunologic evidence of multifocal genital herpes simplex virus 2 infection.

Authors:  Christine Johnston; Jia Zhu; Lichen Jing; Kerry J Laing; Christopher M McClurkan; Alexis Klock; Kurt Diem; Lei Jin; Jeffrey Stanaway; Elizabeth Tronstein; William W Kwok; Meei-Li Huang; Stacy Selke; Youyi Fong; Amalia Magaret; David M Koelle; Anna Wald; Lawrence Corey
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

5.  Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir.

Authors:  A Wald; J Zeh; G Barnum; L G Davis; L Corey
Journal:  Ann Intern Med       Date:  1996-01-01       Impact factor: 25.391

6.  Risk factors for the sexual transmission of genital herpes.

Authors:  G J Mertz; J Benedetti; R Ashley; S A Selke; L Corey
Journal:  Ann Intern Med       Date:  1992-02-01       Impact factor: 25.391

7.  Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera.

Authors:  R L Ashley; J Militoni; F Lee; A Nahmias; L Corey
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

8.  Virus-specific CD8+ T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation.

Authors:  Jia Zhu; David M Koelle; Jianhong Cao; Julio Vazquez; Meei Li Huang; Florian Hladik; Anna Wald; Lawrence Corey
Journal:  J Exp Med       Date:  2007-02-26       Impact factor: 14.307

9.  Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012.

Authors:  Katharine J Looker; Amalia S Magaret; Katherine M E Turner; Peter Vickerman; Sami L Gottlieb; Lori M Newman
Journal:  PLoS One       Date:  2015-01-21       Impact factor: 3.240

Review 10.  Effect of HSV-2 infection on subsequent HIV acquisition: an updated systematic review and meta-analysis.

Authors:  Katharine J Looker; Jocelyn A R Elmes; Sami L Gottlieb; Joshua T Schiffer; Peter Vickerman; Katherine M E Turner; Marie-Claude Boily
Journal:  Lancet Infect Dis       Date:  2017-08-23       Impact factor: 71.421

  10 in total
  3 in total

1.  A Single Herpes Simplex Virus 1 Genome Reactivates from Individual Cells.

Authors:  Dor Rafael; Enosh Tomer; Oren Kobiler
Journal:  Microbiol Spectr       Date:  2022-07-11

2.  Complete Genome Sequence of Herpes Simplex Virus 2 Strain G.

Authors:  Weizhong Chang; Xiaoli Jiao; Hongyan Sui; Suranjana Goswami; Brad T Sherman; Caroline Fromont; Juan Manuel Caravaca; Bao Tran; Tomozumi Imamichi
Journal:  Viruses       Date:  2022-03-05       Impact factor: 5.048

3.  Analytic Characterization of the Herpes Simplex Virus Type 2 Epidemic in the United States, 1950-2050.

Authors:  Houssein H Ayoub; Ibtihel Amara; Susanne F Awad; Ryosuke Omori; Hiam Chemaitelly; Laith J Abu-Raddad
Journal:  Open Forum Infect Dis       Date:  2021-04-29       Impact factor: 3.835

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.